Sponsor hub
Novo Nordisk A/S clinical trial failures
Review 38 stopped clinical trials from Novo Nordisk A/S, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 2 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OTHER/UNKNOWN
- 21
- OPERATIONAL
- 15
- EFFICACY/FUTILITY
- 2
Notable sponsors
- Novo Nordisk A/S
- 38
Related phases
- Phase III
- 18
- Phase I
- 9
- Phase II
- 6
- Phase IV
- 5
Crawlable stopped-trial records
Open ExploreShowing up to 38 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase III Diabetes Mellitus, Type 2 trial by Novo Nordisk A/S. Stop reason: OPERATIONAL.
Due to internal reprioritization, trial was cancelled.
Phase I Chronic Kidney Disease trial by Novo Nordisk A/S. Stop reason: OPERATIONAL.
Business decision
Phase III Diabetes trial by Novo Nordisk A/S. Stop reason: OPERATIONAL.
This trial was terminated due to low recruitment
Phase IV Diabetes trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
See termination reason in detailed description
Phase I Metastatic Castration-resistant Prostate Cancer trial by Novo Nordisk A/S. Stop reason: OPERATIONAL.
Sponsor Decision
Phase III Diabetes Mellitus, Type 2 trial by Novo Nordisk A/S. Stop reason: OPERATIONAL.
Sponsor decision
Phase III Diabetes Mellitus, Type 2 trial by Novo Nordisk A/S. Stop reason: OPERATIONAL.
COVID19 impact on this trial was evaluated and a delay of at least 6-9 months was expected. In parallel, the development of a new type of pen injector, which was an important part of the trial, was ceased and thus this trial was cancelled.
Phase I Rheumatoid Arthritis trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase III Haemophilia A trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
The trial was terminated as the participant withdrew from the trial.
Phase I Overweight trial by Novo Nordisk A/S. Stop reason: OPERATIONAL.
The trial was terminated for strategic reasons.
Phase I Congenital Bleeding Disorder trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
See detailed description
Phase III Diabetes trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase III Diabetes trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
See termination reason in detailed description
Phase III Diabetes trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
See termination reason in detailed description
Phase II Inflammation trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Inflammation trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase III Diabetes trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
See termination reason in detailed description
Phase III Diabetes trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
See termination reason in detailed description
Phase I Metabolism and Nutrition Disorder trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
See detailed description
Phase II Diabetes trial by Novo Nordisk A/S. Stop reason: OPERATIONAL.
The decision to close the NN2211-3619 trial was based on the very low recruitment rate as well as challenges relating to trial execution and study completion.
Phase IV Diabetes trial by Novo Nordisk A/S. Stop reason: OPERATIONAL.
Trial terminated prematurely due to slow recruitment.
Phase IV Diabetes trial by Novo Nordisk A/S. Stop reason: EFFICACY/FUTILITY.
See detailed description
Phase III Chronic Kidney Disease trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
See termination reason in detailed description
Phase III Diabetes trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
The trial was terminated at week 195 due to an insufficient number of subjects remaining to obtain reasonable statistical power
Phase II Cancer trial by Novo Nordisk A/S. Stop reason: OPERATIONAL.
See termination reason in detailed description
Phase III Diabetes trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
See termination reason in detailed description
Phase III Diabetes trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
See termination reason in detailed description
Phase III Diabetes trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
See termination reason in detailed description
Phase III Diabetes trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
See termination reason in detailed description
Phase III Diabetes trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
See termination reason in detailed description
Phase III Menopause trial by Novo Nordisk A/S. Stop reason: OPERATIONAL.
Trial prematurely discontinued due to slow recruitment
Phase II Acquired Bleeding Disorder trial by Novo Nordisk A/S. Stop reason: OPERATIONAL.
Trial enrollment was prematurely terminated due to excessively slow patient recruitment
Phase IV Growth Hormone Disorder trial by Novo Nordisk A/S. Stop reason: OPERATIONAL.
The trial was prematurely terminated due to low recruitment
Phase IV Diabetes trial by Novo Nordisk A/S. Stop reason: OPERATIONAL.
Low recruitment status
Phase I Inflammation trial by Novo Nordisk A/S. Stop reason: EFFICACY/FUTILITY.
Trial discontinued due to apparent lack of response in psoriasis measures. No safety concerns were present
Phase II Acquired Bleeding Disorder trial by Novo Nordisk A/S. Stop reason: OPERATIONAL.
Trial terminated after recruiting 172 patients but without proceeding to the highest dosing cohort as this no longer reflects common clinical practice
Phase I Metabolism and Nutrition Disorder trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
The trial is terminated due to re-evaluation of the compound
Phase I Haemostasis trial by Novo Nordisk A/S. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.